Change in Thrombin Generation Potential and Thromboelastography During the Menstrual Cycle

Stopped early

Conditions studied: Von Willebrand Disease

In brief

The primary objective of this study is to describe characteristics and trends for thrombin generation (TG) and thromboelastography (TEG) at 4 time points during the menstrual cycle.

Key facts

Study ID

NCT00178542

Run by

The University of Texas Health Science Center, Houston

People needed

20

Starts

2005-09-01

Expected to finish

2013-04-01

Last updated by the study team

2013-05-06

Who can join

Age: 18 and older, up to 50. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Females of reproductive age with regular menstrual cycles and a diagnosis of von Willebrand disease according to the International Society of Thrombosis and Hemostasis diagnostic criteria.

You may not qualify if…

• Females who are pregnant, or have a history of endocrinopathy or hormone imbalance
• History of hysterectomy or bilateral oophorectomy
• History of ovarian or uterine cancer
• Use of intrauterine device
• Use of antifibrinolytic therapy, hemostatic agents, or anti-platelet agents.

Where it is running

• The University of Texas Health Science Center at Houston — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.